54
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Allergic conditions are not associated with the risk of non-Hodgkin’s lymphoma or Hodgkin’s lymphoma: a systematic review and meta-analysis

, , , , &
Pages 2189-2198 | Published online: 18 Apr 2017

References

  • FerlayJShinHRBrayFFormanDMathersCParkinDMEstimates of worldwide burden of cancer in 2008: GLOBOCAN 2008Int J Cancer2010127122893291721351269
  • RudantJOrsiLMonnereauAChildhood Hodgkin’s lymphoma, non-Hodgkin’s lymphoma and factors related to the immune system: the Escale Study (SFCE)Int J Cancer201112992236224721170962
  • GrulichAEVajdicCMCozenWAltered immunity as a risk factor for non-Hodgkin lymphomaCancer Epidemiol Biomarkers Prev200716340540817337643
  • MelbyeMSmedbyKELehtinenTAtopy and risk of non-Hodgkin lymphomaJ Natl Cancer Inst200799215816617227999
  • WangHDiepgenTLIs atopy a protective or a risk factor for cancer? A review of epidemiological studiesAllergy20056091098111116076292
  • WangJMackTMHamiltonASCommon immune-related exposures/conditions and risk of non-Hodgkin lymphoma: a case-control study of disease-discordant twin pairsAm J Epidemiol2015182541742526271116
  • DikaliotiSKChangETDessyprisNAllergy-associated symptoms in relation to childhood non-Hodgkin’s as contrasted to Hodgkin’s lymphomas: a case-control study in Greece and meta-analysisEur J Cancer201248121860186622230747
  • GrulichAEVajdicCMKaldorJMBirth order, atopy, and risk of non-Hodgkin lymphomaJ Natl Cancer Inst200597858759415840881
  • VajdicCMFalsterMOde SanjoseSAtopic disease and risk of non-Hodgkin lymphoma: an InterLymph pooled analysisCancer Res200969166482648919654312
  • LiuXHemminkiKForstiASundquistJSundquistKJiJCancer risk and mortality in asthma patients: a Swedish national cohort studyActa Oncol20155481120112725608824
  • HofmannJNHoppinJALynchCFFarm characteristics, allergy symptoms, and risk of non-Hodgkin lymphoid neoplasms in the agricultural health studyCancer Epidemiol Biomarkers Prev201524358759425583946
  • KoshiolJLamTKGridleyGCheckDBrownLMLandgrenORacial differences in chronic immune stimulatory conditions and risk of non-Hodgkin’s lymphoma in veterans from the United StatesJ Clin Oncol201129437838521172877
  • MoherDLiberatiATetzlaffJAltmanDGGroupPPreferred reporting items for systematic reviews and meta-analyses: the PRISMA statementPLoS Med200967e100009719621072
  • HigginsJPThompsonSGQuantifying heterogeneity in a meta-analysisStat Med200221111539155812111919
  • HollanderPRostgaardKSmedbyKEAutoimmune and atopic disorders and risk of classical Hodgkin lymphomaAm J Epidemiol2015182762463226346543
  • HelbyJBojesenSENielsenSFNordestgaardBGIgE and risk of cancer in 37 747 individuals from the general populationAnn Oncol20152681784179025969367
  • NietersALuczynskaABeckerSPrediagnostic immunoglobulin E levels and risk of chronic lymphocytic leukemia, other lymphomas and multiple myeloma-results of the European Prospective Investigation into Cancer and NutritionCarcinogenesis201435122716272225269801
  • LinaberyAMPrizmentAEAndersonKECerhanJRPoynterJNRossJAAllergic diseases and risk of hematopoietic malignancies in a cohort of postmenopausal women: a report from the Iowa Women’s Health StudyCancer Epidemiol Biomarkers Prev20142391903191224962839
  • LinaberyAMErhardtEBFonstadRKInfectious, autoimmune and allergic diseases and risk of Hodgkin lymphoma in children and adolescents: a Children’s Oncology Group studyInt J Cancer201413561454146924523151
  • HemminkiKForstiAFallahMSundquistJSundquistKJiJRisk of cancer in patients with medically diagnosed hay fever or allergic rhinitisInt J Cancer2014135102397240324692097
  • ChenYJWuCYShenJLChenTTChangYTCancer risk in patients with chronic urticaria: a population-based cohort studyArch Dermatol2012148110310822250240
  • CerhanJRFredericksenZSWangAHDesign and validity of a clinic-based case-control study on the molecular epidemiology of lymphomaInt J Mol Epidemiol Genet2011229511321686124
  • El-ZeinMParentMEKaKSiemiatyckiJSt-PierreYRousseauMCHistory of asthma or eczema and cancer risk among men: a population-based case-control study in Montreal, Quebec, CanadaAnn Allergy Asthma Immunol2010104537838420486327
  • PahwaPKarunanayakeCPSpinelliJJDosmanJAMcDuffieHHEthnicity and incidence of Hodgkin lymphoma in Canadian populationBMC Cancer2009914119432977
  • ErberELimUMaskarinecGKolonelLNCommon immune-related risk factors and incident non-Hodgkin lymphoma: the multiethnic cohortInt J Cancer200912561440144519444913
  • CozenWHamiltonASZhaoPA protective role for early oral exposures in the etiology of young adult Hodgkin lymphomaBlood2009114194014402019738032
  • Ellison-LoschmannLBenaventeYDouwesJImmunoglobulin E levels and risk of lymphoma in a case-control study in SpainCancer Epidemiol Biomarkers Prev20071671492149817627016
  • CozenWCerhanJRMartinez-MazaOThe effect of atopy, childhood crowding, and other immune-related factors on non-Hodgkin lymphoma riskCancer Causes Control200718882183117588155
  • BeckerNde SanjoseSNietersABirth order, allergies and lymphoma risk: results of the European collaborative research project EpilymphLeuk Res200731101365137217481729
  • SoderbergKCJonssonFWinqvistOHagmarLFeychtingMAutoimmune diseases, asthma and risk of haematological malignancies: a nationwide case-control study in SwedenEur J Cancer200642173028303316945522
  • BracciPMDalviTBHollyEAResidential history, family characteristics and non-Hodgkin lymphoma, a population-based case-control study in the San Francisco Bay AreaCancer Epidemiol Biomarkers Prev20061571287129416835325
  • ErikssonNEMikoczyZHagmarLCancer incidence in 13811 patients skin tested for allergyJ Investig Allergol Clin Immunol2005153161166
  • BeckerNDeegERudigerTNietersAMedical history and risk for lymphoma: results of a population-based case-control study in GermanyEur J Cancer200541113314215617998
  • ZhangYHolfordTRLeadererBPrior medical conditions and medication use and risk of non-Hodgkin lymphoma in Connecticut United States womenCancer Causes Control200415441942815141141
  • SoderbergKCHagmarLSchwartzbaumJFeychtingMAllergic conditions and risk of hematological malignancies in adults: a cohort studyBMC Public Health200445115527506
  • HollyEABracciPMPopulation-based study of non-Hodgkin lymphoma, histology, and medical history among human immunodeficiency virus-negative participants in San FranciscoAm J Epidemiol2003158431632712915497
  • BriggsNCLevineRSBrannEAAllergies and risk of non-Hodgkin’s lymphoma by subtypeCancer Epidemiol Biomarkers Prev200211440140711927501
  • Fabbro-PerayPDauresJPRossiJFEnvironmental risk factors for non-Hodgkin’s lymphoma: a population-based case-control study in Languedoc-Roussillon, FranceCancer Causes Control200112320121211405325
  • VineisPCrosignaniPSacerdoteCHaematopoietic cancer and medical history: a multicentre case control studyJ Epidemiol Community Health200054643143610818118
  • HollyEALeleCBracciPMMcGrathMSCase-control study of non-Hodgkin’s lymphoma among women and heterosexual men in the San Francisco Bay Area, CaliforniaAm J Epidemiol1999150437538910453814
  • VesterinenEPukkalaETimonenTAromaaACancer incidence among 78,000 asthmatic patientsInt J Epidemiol19932269769828144310
  • La VecchiaCNegriEFranceschiSMedical history and the risk of non-Hodgkin’s lymphomasCancer Epidemiol Biomarkers Prev1992175335361302565
  • DoodyMMLinetMSGlassAGLeukemia, lymphoma, and multiple myeloma following selected medical conditionsCancer Causes Control1992354494561525326
  • BernsteinLRossRKPrior medication use and health history as risk factors for non-Hodgkin’s lymphoma: preliminary results from a case-control study in Los Angeles CountyCancer Res19925219 suppl5510s5515s1394165
  • FranceschiSSerrainoDBidoliEThe epidemiology of non-Hodgkin’s lymphoma in the north-east of Italy: a hospital-based case-control studyLeuk Res19891364654722770331
  • CartwrightRAMcKinneyPAO’BrienCNon-Hodgkin’s lymphoma: case control epidemiological study in YorkshireLeuk Res198812181883357350
  • TielschJMLinetMSSzkloMAcquired disorders affecting the immune system and non-Hodgkin’s lymphomaPrev Med1987161961063823013
  • MortonLMSlagerSLCerhanJREtiologic heterogeneity among non-Hodgkin lymphoma subtypes: the InterLymph Non-Hodgkin Lymphoma Subtypes ProjectJ Natl Cancer Inst Monogr201420144813014425174034
  • CardTRSolaymani-DodaranMHubbardRLoganRFWestJIs an internal comparison better than using national data when estimating mortality in longitudinal studies?J Epidemiol Community Health200660981982116905729
  • GrulichAEVajdicCMRimintonSHughesAMKrickerAArmstrongBKRe: atopy and risk of non-Hodgkin lymphomaJ Natl Cancer Inst20079918141717848674
  • OlsonSHHsuMSatagopanJMAllergies and risk of pancreatic cancer: a pooled analysis from the Pancreatic Cancer Case-Control ConsortiumAm J Epidemiol2013178569170023820785
  • HsiaoJROuCYLoHIAllergies and risk of head and neck cancer: an original study plus meta-analysisPLoS One201382e5513823383309
  • MarkiewiczMAGajewskiTFThe immune system as anti-tumor sentinel: molecular requirements for an anti-tumor immune responseCrit Rev Oncog199910324726010468184
  • Jensen-JarolimEAchatzGTurnerMCAllergoOncology: the role of IgE-mediated allergy in cancerAllergy200863101255126618671772
  • StrikMCde KoningPJKleijmeerMJHuman mast cells produce and release the cytotoxic lymphocyte associated protease granzyme B upon activationMol Immunol200744143462347217485116